Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities

SK Pirooznia, F Elefant - Frontiers in cellular neuroscience, 2013 - frontiersin.org
Dynamic epigenetic regulation of neurons is emerging as a fundamental mechanism by
which neurons adapt their transcriptional responses to specific developmental and …

Modulating epigenetic HAT activity for reinstating acetylation homeostasis: a promising therapeutic strategy for neurological disorders

SA Ganai, S Banday, Z Farooq, M Altaf - Pharmacology & Therapeutics, 2016 - Elsevier
Epigenetic mechanisms are emerging as a fundamental regulatory switch in neuronal
function. Acetylation homeostasis governed by the antagonistic activities of HATs and …

Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis

S Forostyak, P Jendelova, M Kapcalova, D Arboleda… - …, 2011 - Taylor & Francis
Background aims. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative
disorder characterized by the loss of brain and spinal cord motor neurons (MN). The …

Vitamin A deficiency impairs spatial learning and memory: the mechanism of abnormal CBP-dependent histone acetylation regulated by retinoic acid receptor alpha

N Hou, L Ren, M Gong, Y Bi, Y Gu, Z Dong, Y Liu… - Molecular …, 2015 - Springer
Vitamin A (VA) is an essential micronutrient. Numerous studies have confirmed that VA
deficiency (VAD) leads to a decline in learning and memory function. Our previous studies …

Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper …

E Tokuda, E Okawa, S Watanabe, S Ono… - Neurobiology of …, 2013 - Elsevier
Over 170 mutations in superoxide dismutase-1 (SOD1) have been linked to amyotrophic
lateral sclerosis (ALS). The properties of SOD1 mutants differ considerably including copper …

Epigenetic mechanisms of gene regulation in amyotrophic lateral sclerosis

A Jimenez-Pacheco, JM Franco, S Lopez… - … in Aging and Disease, 2017 - Springer
Despite being clinically described 150 years ago, the mechanisms underlying amyotrophic
lateral sclerosis (ALS) pathogenesis have not yet been fully understood. Studies in both …

Neuromuscular effects of G93A-SOD1 expression in zebrafish

SA Sakowski, JS Lunn, AS Busta, SS Oh… - Molecular …, 2012 - Springer
Background Amyotrophic lateral sclerosis (ALS) is a fatal disorder involving the
degeneration and loss of motor neurons. The mechanisms of motor neuron loss in ALS are …

The peripheral nervous system in amyotrophic lateral sclerosis: opportunities for translational research

F Gentile, S Scarlino, YM Falzone, C Lunetta… - Frontiers in …, 2019 - frontiersin.org
Although amyotrophic lateral sclerosis (ALS) has been considered as a disorder of the motor
neuron (MN) cell body, recent evidences show the non-cell-autonomous pathogenic nature …

Valproic acid regulates antioxidant enzymes and prevents ischemia/reperfusion injury in the rat retina

ZZ Zhang, XH Qin, XF Zhao, N Tong, YY Gong… - Current eye …, 2012 - Taylor & Francis
Purposes: To investigate whether valproic acid (VPA) has a neuroprotective effect against
ischemia/reperfusion (I/R) injury in the rat retina, and to elucidate the potential antioxidant …

Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS

GB Chiarotto, LP Cartarozzi, M Perez… - Journal of …, 2019 - Springer
Background The development of new therapeutic strategies to treat amyotrophic lateral
sclerosis (ALS) is of utmost importance. The use of cyclic nitroxides such as tempol may …